Excess Early Mortality in Schizophrenia

Annual Review of Clinical Psychology - Tập 10 Số 1 - Trang 425-448 - 2014
Thomas Munk Laursen1,2, Merete Nordentoft3,2, Preben Bo Mortensen1,2
1National Center for Register-Based Research, Aarhus University, 8210 Aarhus V, Denmark;
2The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPsych), 8210 Aarhus V, Denmark
3Psychiatric Center Copenhagen, Faculty of Health Sciences, University of Copenhagen, Copenhagen, DK 2200 Denmark

Tóm tắt

Schizophrenia is often referred to as one of the most severe mental disorders, primarily because of the very high mortality rates of those with the disorder. This article reviews the literature on excess early mortality in persons with schizophrenia and suggests reasons for the high mortality as well as possible ways to reduce it. Persons with schizophrenia have an exceptionally short life expectancy. High mortality is found in all age groups, resulting in a life expectancy of approximately 20 years below that of the general population. Evidence suggests that persons with schizophrenia may not have seen the same improvement in life expectancy as the general population during the past decades. Thus, the mortality gap not only persists but may actually have increased. The most urgent research agenda concerns primary candidates for modifiable risk factors contributing to this excess mortality, i.e., side effects of treatment and lifestyle factors, as well as sufficient prevention and treatment of physical comorbidity.

Từ khóa


Tài liệu tham khảo

10.1111/j.1600-0447.1988.tb05184.x

Alstrøm CH, 1942, Mortality in Mental Hospitals

10.1016/S0920-9964(02)00328-6

10.1176/appi.ajp.163.11.1934

10.1080/01612840590959551

10.4088/JCP.v68n0614

10.1016/S0165-0327(99)00004-X

10.1111/j.1600-0447.1997.tb09629.x

10.1016/j.schres.2010.02.1030

10.1186/1471-244X-12-78

10.1176/appi.ajp.157.12.1925

10.2190/PM.43.4.d

10.1192/bjp.171.6.502

10.1192/bjp.bp.109.067512

10.1016/j.schres.2012.03.017

10.1093/schbul/16.4.571

10.1192/bjp.182.2.117

10.1097/01.psy.0000237316.09601.88

10.1111/j.1525-1497.2006.00563.x

Cent. Prev. Board Health, 2006, Fysisk aktivitet i psykiatrien—undervisningsmateriale. [Physical activity in psychiatry—educational material.]

10.1371/journal.pone.0019590

10.1016/0021-9681(87)90171-8

10.1080/10673220600889256

10.1176/appi.ps.53.7.874

10.1176/appi.ajp.2012.12050599

10.1056/NEJMoa1214530

10.1016/j.schres.2008.07.006

10.1097/00005053-200201000-00014

10.1177/1403494812457734

10.1093/schbul/sbp115

10.1001/archpsyc.58.6.565

10.1001/archgenpsychiatry.2010.157

10.1176/appi.ajp.163.3.521

10.1016/0920-9964(92)90001-L

10.1097/PSY.0b013e318230343f

10.1001/archinte.165.22.2631

10.1016/j.schres.2005.08.010

Goodwin FK, 2007, Manic-Depressive Illness. Bipolar Disorders and Recurrent Depression., 2

10.1192/bjp.117.539.437

10.1192/bjp.170.3.205

10.1192/bjp.173.1.11

10.1016/S0140-6736(08)61871-1

10.1136/bmjopen-2012-001810

10.1136/hrt.2006.110171

10.1192/bjp.172.1.35

10.3371/CSRP.4.3.2

10.1192/bjp.179.6.498

Juel K, Sørensen J, Brønnum-Hansen H. 2006. Risk factors and public health in Denmark. Copenhagen: Natl. Inst. Public Health

10.1016/S0140-6736(08)60486-9

10.4088/JCP.08m04718yel

10.1007/s11920-000-0019-1

Khan A, Faucett J, Morrison S, Brown WA. 2013. Comparative mortality risk in adult patients with schizophrenia, depression, bipolar disorder, anxiety disorders, and attention-deficit/hyperactivity disorder participating in psychopharmacology clinical trials. JAMA Psychiatry 70:1091–99

10.1001/archpsyc.63.3.250

10.1093/schbul/sbm140

10.1192/bjp.bp.109.067082

10.1503/cmaj.060482

10.1007/s00127-012-0478-9

Lahti M, Tiihonen J, Wildgust H, Beary M, Hodgson R, et al. 2012. Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia. Psychol. Med. 12:1–11

10.1016/j.schres.2011.06.008

10.1001/archpsyc.62.8.841

Laursen TM, Mortensen PB, MacCabe JH, Cohen D, Gasse C. 2013a. Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder. A Danish population-based study. Psychol. Med. 18:1–13

10.1001/archgenpsychiatry.2009.61

10.1371/journal.pone.0024597

10.4088/JCP.v68n0612

10.1097/YCO.0b013e32835035ca

10.1016/j.jpsychires.2010.04.027

10.1371/journal.pone.0067133

10.1034/j.1600-0447.2000.101005382.x

10.1177/070674371005501202

10.1192/bjp.182.1.31

10.1111/j.1440-1819.1995.tb01912.x

10.1093/epirev/mxn001

10.1016/j.psc.2007.04.007

10.1097/00005053-197704000-00002

Miller WR, 1991, Motivational Interviewing: Preparing People for Change

Mitchell AJ, 2010, J. Psychol. Pharmacol., 24, 69

Moller HJ, 2003, J. Clin. Psychiatry, 64, 23

10.1016/S0920-9964(99)00030-4

10.1177/1403494810395825

10.1016/S0140-6736(99)06376-X

10.1111/j.1600-0447.1990.tb05466.x

10.1192/bjp.163.2.183

10.1016/j.schres.2004.03.002

Newcomer JW, 2007, J. Clin. Psychiatry, 68, 8

10.1001/jama.298.15.1794

10.1093/schbul/sbs148

10.1016/j.schres.2013.02.025

Nordentoft M, 2012, Psykisk Sygdom og ændringer i Livsstil. [Psychiatric Disease and Lifestyle Changes.]

10.1136/bmj.38133.622488.63

10.1001/archgenpsychiatry.2011.113

10.1371/journal.pone.0055176

Odegard O, 1951, Acta Gen. Stat. Med., 2, 141

10.1093/oxfordjournals.schbul.a033407

10.1186/1471-244X-8-84

10.1001/archpsyc.58.9.844

10.1016/S0920-9964(99)00191-7

10.1001/archpsyc.62.3.247

Pedersen CB, 2006, Dan. Med. Bull., 53, 441

10.1093/aje/kwj169

Pedersen PV, 2012, SUSY Udsat 2012. Sundhedsprofil for social udsatte i Danmark 2012 og udviklingen siden 2007. [SUSY Exposed 2012. Health profile for socially vulnerable groups in Denmark 2012 and developments since 2007.]

10.1093/eurheartj/ehs092

10.1111/1475-6773.00104

10.1186/1472-6963-7-146

Prochaska JO, 1992, Prog. Behav. Modif., 28, 183

10.1001/archpsyc.62.4.427

10.1097/YCO.0b013e32833f46c9

10.1093/ije/dyq267

10.1136/bmj.c3222

10.1001/archpsyc.64.10.1123

10.1371/journal.pmed.0020141

10.1016/S0140-6736(12)61680-8

10.1249/MSS.0b013e318258e120

10.1016/j.euroneuro.2012.08.008

10.1016/j.schres.2011.04.011

Shorter E, 1997, A History of Psychiatry

10.2975/29.2005.122.127

10.1176/appi.ajp.2010.08040484

10.1016/j.jclinepi.2004.03.012

10.1002/gps.2833

10.1111/j.1600-0447.2010.01563.x

10.1017/S0033291707009944

10.1016/S0140-6736(09)60742-X

10.1016/S0140-6736(11)60211-0

10.1016/S0920-9964(99)00107-3

Tsoi DT, 2013, Cochrane Database Syst. Rev., 2, CD007253

van der Werf M, Hanssen M, Kohler S, Verkaaik M, Verhey FR, et al. 2012. Systematic review and collaborative recalculation of 133 693 incident cases of schizophrenia. Psychol. Med. 44:9–16

10.1002/(SICI)1096-8628(19970221)74:1<7::AID-AJMG2>3.0.CO;2-S

10.1176/appi.ps.57.8.1145

10.1093/eurpub/ckr068

10.4088/JCP.11m07522

World Health Organ, 1994, International Classification of Diseases., 10

World Health Organ. 1994b. WHO ICD-10:Psykiske Lidelser og Adfærdsmæssige Forstyrrelser. Klassifikation og Diagnosekriterier.[WHO ICD-10: Mental and Behavioral Disorders. Classification and Diagnostic Criteria.] Copenhagen: Munksgaard Danmark